**What is already known about the topic?**

-   Informal caregivers of patients with amyotrophic lateral sclerosis (ALS) experience increased caregiver burden during the disease course of the patient.

-   Little is known regarding which caregiver factors and which patient factors influence caregiver burden in ALS.

**What this paper adds?**

-   This systematic review offers a comprehensive overview of both patient and caregiver factors related to caregiver burden in informal caregivers of patients with ALS.

-   Higher caregiver burden is associated with greater behavioral and physical impairment of the patient and with more depressive feelings of the caregiver.

**Implications for practice, theory, or policy**

-   This knowledge enables the identification of caregivers of people with ALS who are at risk for caregiver burden.

-   This knowledge informs the development of interventions focusing on diminishing burden in caregivers of ALS patients.

-   More studies are needed that examine caregiver-related factors (such as feelings of competence in caregiving or self-efficacy) in relation to caregiver burden.

Introduction {#section7-0269216317709965}
============

Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease that causes severe restrictions in physical functioning. Patients suffer from progressive weakness of voluntary muscles and approximately 30%--50% of the ALS patients experience cognitive impairments.^[@bibr1-0269216317709965],[@bibr2-0269216317709965]^ The disease leads to an increasing need for care; a major role in this care process is fulfilled by informal caregivers (family, friends, and neighbors).

Caring for an ALS patient is a demanding task. During the course of the disease, the patient may require support with all activities of daily living such as eating, transportation, and medical care.^[@bibr3-0269216317709965]^ Furthermore, caregivers often struggle with accepting this fatal disease, their increased responsibilities, concerns about the future, and feelings of guilt.^[@bibr4-0269216317709965]^ Findings from longitudinal studies indicate that caregivers of patients with ALS experience increasing levels of physical and emotional distress, often referred to as caregiver burden.^[@bibr5-0269216317709965],[@bibr6-0269216317709965]^ Caregiver burden is defined as the impact on the emotional health, physical health, social life, and the financial status of the caregiver as a result of adopting the caregiving role.^[@bibr7-0269216317709965]^

The well-being of caregivers is essential in ALS care; their capacity proves to be an important factor in enabling ALS patients to remain at home until the end of their lives rather than going into a care facility.^[@bibr8-0269216317709965]^ Moreover, studies show a high concordance between the well-being of the patient and that of the caregiver, indicating that a reduced well-being of the caregiver can negatively impact the well-being of the patient.^[@bibr9-0269216317709965][@bibr10-0269216317709965]--[@bibr11-0269216317709965]^

Knowledge about which factors relate to caregiver burden is needed in order to develop interventions to support caregivers. During the last decade, three reviews have been published concerning the well-being of ALS caregivers, but a comprehensive overview of both modifiable and non-modifiable patient and caregiver factors influencing caregiver burden is lacking.^[@bibr12-0269216317709965][@bibr13-0269216317709965]--[@bibr14-0269216317709965]^ The objective of this study, therefore, was to systematically review published literature to investigate which caregiver and patient factors are related to caregiver burden in informal caregivers of patients with ALS.

Methods {#section8-0269216317709965}
=======

We followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines,^[@bibr15-0269216317709965]^ see Supplementary Appendix 1. This systematic review has been registered with PROSPERO 2015 CRD42015019842.

Search strategy {#section9-0269216317709965}
---------------

The electronic databases PsycINFO, Medline (PubMed), CINAHL, and EMBASE were systematically searched using the following keywords, along with synonyms: "amyotrophic lateral sclerosis," "burden," and "caregiver." A clinical librarian was consulted regarding the search strategy, which is presented in the online Supplementary Appendix 2. No constraint was placed on the year of publication; searches were conducted up to 2017. Additionally, references were checked for relevant publications. To make sure that no relevant papers had been missed, we sent a list of papers identified through the search to researchers in the field of ALS care for their review.

Inclusion criteria {#section10-0269216317709965}
------------------

Studies that investigated quantitative relationships between caregiver or patient factors and caregiver burden in informal ALS caregivers were included. Factors had to be explicitly defined and in case of self-reported constructs measured with a validated questionnaire or a clearly described single question. Burden had to be assessed with a total caregiver burden construct. Only full-text articles, published in peer-reviewed journals, in English, Dutch, or German, were considered eligible.

Exclusion criteria {#section11-0269216317709965}
------------------

Mixed sample studies---studies where caregivers of patients with different diagnoses are grouped together---were excluded, unless subsample analysis was performed for ALS caregivers. Studies that described the association solely with subscales of burden measures, or studies that combined burden with other outcomes measures into one overarching outcomes measure, were not taken into account. Intervention studies, qualitative studies, reviews, and case reports were excluded.

Study selection {#section12-0269216317709965}
---------------

The titles and abstracts of the articles were independently screened for relevance by two reviewers (J.d.W. and A.C.v.G.); relevant publications, potentially eligible for inclusion, were read in full text by two reviewers (J.d.W. and L.A.B.). Disagreements were resolved by discussion until consensus was reached. Authors of the studies in the review were contacted by e-mail when information was missing.

Risk of bias assessment {#section13-0269216317709965}
-----------------------

The risk of bias of the included studies was assessed independently by the two researchers who assessed the full-text articles (J.d.W. and L.A.B.). The Methodological Quality Assessment List,^[@bibr16-0269216317709965],[@bibr17-0269216317709965]^ an 8-point checklist that yields a total score between 0 (low methodological quality) and 8 (high methodological quality), was used (Supplementary Appendix 3). Since this checklist was originally applied to research on patients, the relevant characteristics to score item 3 "external validity" were changed into "caregiver age, gender, type of relationship with patient, physical functioning of the patient and time since patient's diagnosis." Studies with a total score below 3 were excluded from the quality of evidence assessment. In case of disagreement, a third author was consulted.

Data synthesis {#section14-0269216317709965}
--------------

Data were independently extracted from eligible papers by two researchers (J.d.W. and L.A.B.) using structured data forms that were developed for this study and included key components of the study characteristics, study results, and methodological quality of the studies. Due to the diversity of outcome measures and factors included in the study, a meta-analysis was not possible. Bivariate and multivariate associations were described separately in terms of correlation coefficients (*r*) and standardized *β*-coefficients (*β*). In studies that applied a logistic regression, the odds ratio (OR) was presented. Factors were grouped into patient and caregiver characteristics and subsequently thematically categorized.

Quality of evidence {#section15-0269216317709965}
-------------------

The Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach was used to assess the overall quality of evidence for each factor measured in at least three studies (Supplementary Appendix 4).^[@bibr18-0269216317709965]^ Two researchers (J.d.W. and L.A.B.) rated the factors on the GRADE criteria study limitations (here we used the Methodological Quality Assessment List), inconsistency, indirectness, imprecision, and publication bias. The criteria "dose effect" and "moderate/large effect" were omitted, since these criteria were not relevant for the quality of evidence in our review. The overall quality of evidence was classified as high, moderate, low, or very low.

Results {#section16-0269216317709965}
=======

Studies selected {#section17-0269216317709965}
----------------

The search identified a total of 1126 possibly relevant articles. After the removal of duplicates and the abstract and full-text screening, a total of 25 studies were left for inclusion in the review ([Figure 1](#fig1-0269216317709965){ref-type="fig"}). Two study samples were described in two articles each.^[@bibr19-0269216317709965][@bibr20-0269216317709965][@bibr21-0269216317709965]--[@bibr22-0269216317709965]^ Since these articles investigated different factors in relation to burden, they were retained for review.

![Search flowchart.](10.1177_0269216317709965-fig1){#fig1-0269216317709965}

Risk of bias {#section18-0269216317709965}
------------

The methodological quality scores of the studies ranged from 2 to 7 out of a maximum of 8 (high quality) points (Supplementary Appendix 5). One study scored a low total score, indicating a high risk of bias, and was not incorporated in the quality of evidence assessment.^[@bibr23-0269216317709965]^ The following items of the Methodological Quality Assessment List were not met by the majority of the studies: study participation, proportion sample size versus factors, and confounding bias.

Description of studies included {#section19-0269216317709965}
-------------------------------

The key characteristics of each study are presented in [Table 1](#table1-0269216317709965){ref-type="table"}. The included studies were published in eight different countries between 1998 and 2016 and the majority was published in the last decade. A total of 20 studies used a cross-sectional design and 5 studies used a longitudinal design. A total of 22 studies investigated univariate associations; in 10 studies, associations were explored in multivariate models. The study samples ranged from 19 to 415 caregivers. Among the studies that reported the caregiver's relationship with the patient (*n* = 22), partners dominated the sample (range, 63%--100%), with two studies recruiting partners only. Other relationships included children, siblings, parents, friends, neighbors, and other relatives. Caregivers were predominantly female and the mean age of caregivers varied from 48 to 61 years. The mean time since disease onset ranged from 15 to 40 months.

###### 

The summary of included studies.

![](10.1177_0269216317709965-table1)

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Authors (Year)                                         Country           Design (follow-up)^[a](#table-fn2-0269216317709965){ref-type="table-fn"}^       Caregiver sample, *n* (% female)                                     Spouse of the patient (%)   Age in years caregivers, mean (SD)   Time since disease onset (o), time since diagnosis (d)\              ALSFRS, mean (SD)
                                                                                                                                                                                                                                                                                                 Mean (SD) months                                                     
  ------------------------------------------------------ ----------------- ------------------------------------------------------------------------------- -------------------------------------------------------------------- --------------------------- ------------------------------------ -------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------
  Andrews et al. (2016)^[@bibr24-0269216317709965]^      Australia         Cross-sectional                                                                 40 (78)                                                              n.r.                        56 (14.5)                            26 (14.2), o                                                         35.3 (8.9)^[R](#table-fn1-0269216317709965){ref-type="table-fn"}^

  Bock et al. (2016)^[@bibr25-0269216317709965]^         USA               Cross-sectional                                                                 86 (n.r.)                                                            n.r.                        n.r.                                 26 (48.6), o[\*](#table-fn1-0269216317709965){ref-type="table-fn"}   33.5 (11.1)^[R](#table-fn1-0269216317709965){ref-type="table-fn"}[\*](#table-fn1-0269216317709965){ref-type="table-fn"}^

  Burke et al. (2015)^[@bibr26-0269216317709965]^        Ireland           Cross-sectional                                                                 33 (66)                                                              81.3                        58 (11.1)                            30 (18.2), o                                                         36.6 (7.8)^[R](#table-fn1-0269216317709965){ref-type="table-fn"}^

  Chio et al. (2005)^[@bibr10-0269216317709965]^         Italy             Cross-sectional                                                                 60 (63)                                                              76.7                        58 (12.3)                            28 (25.2), o                                                         24.6 (10.6)

  Chio et al. (2010)^[@bibr27-0269216317709965]^         Italy             Cross-sectional                                                                 70 (67)                                                              80.0                        55 (13.3)                            17 (9.3), o                                                          29.2 (6.1)

  Creemers et al. (2015)^[@bibr5-0269216317709965]^      The Netherlands   Longitudinal (12 months)                                                        126 (66)                                                             85.0                        59 (12.5)                            25 (n.r.), o[\*](#table-fn1-0269216317709965){ref-type="table-fn"}   31.8 (8.2)^[R](#table-fn1-0269216317709965){ref-type="table-fn"}^

  Galvin et al. (2016)^[@bibr28-0269216317709965]^       Ireland           Cross-sectional                                                                 81 (70)                                                              71.6                        55 (13.4)                            n.r.                                                                 n.r.

  Gauthier et al. (2007)^[@bibr6-0269216317709965]^      Italy             Longitudinal (9 months)                                                         31 (71)                                                              80.6                        55 (11.3)                            40 (31.5), o                                                         28.7 (7.0)

  Geng et al. (2016)^[@bibr29-0269216317709965]^         China             Cross-sectional                                                                 81 (68)                                                              67.9                        48 (14.5)                            17.8 (14.9), o                                                       36.5 (8.6)

  Goldstein et al. (1998)^[@bibr20-0269216317709965]^    UK                Cross-sectional                                                                 19 (53)                                                              100                         60 (12.6)                            34 (23.9), o                                                         n.r.

  Goldstein et al. (2000)^[@bibr19-0269216317709965]^    UK                Cross-sectional                                                                 19 (53)                                                              100                         60 (12.6)                            34 (23.9), o                                                         n.r.

  Hecht et al. (2003)^[@bibr30-0269216317709965]^        Germany           Cross-sectional                                                                 37 (73)                                                              81.1                        57 (13.4)                            25 (26.6), d                                                         23.5 (9.1)

  Jenkinson et al. (2000)^[@bibr31-0269216317709965]^    UK                Cross-sectional                                                                 415 (n.r.)                                                           79.6                        55 (13.1)                            26 (29.5), o                                                         25.9 (28.8)

  Lillo et al. (2012)^[@bibr32-0269216317709965]^        Australia         Cross-sectional                                                                 140 (69)                                                             90.0                        61 (12.0)                            36 (n.r.), o[\*](#table-fn1-0269216317709965){ref-type="table-fn"}   30.4 (9.7)^[R](#table-fn1-0269216317709965){ref-type="table-fn"}^

  Pagnini et al. (2010)^[@bibr22-0269216317709965]^      Italy             Cross-sectional                                                                 40 (70; 78)^[b](#table-fn3-0269216317709965){ref-type="table-fn"}^   82.5                        56 (12.3)                            15 (n.r.), o                                                         34.9 (7.8)^[R](#table-fn1-0269216317709965){ref-type="table-fn"}^

  Pagnini et al. (2011)^[@bibr33-0269216317709965]^      Italy             Cross-sectional                                                                 37 (62)                                                              86.5                        55 (11.4)                            21 (4.2), o                                                          27.8 (14.7)^[R](#table-fn1-0269216317709965){ref-type="table-fn"}^

  Pagnini et al. (2012)^[@bibr21-0269216317709965]^      Italy             Cross-sectional                                                                 40 (70; 78)^[b](#table-fn3-0269216317709965){ref-type="table-fn"}^   82.5                        56 (12.3)                            15 (n.r.), o                                                         34.9 (7.8)^[R](#table-fn1-0269216317709965){ref-type="table-fn"}^

  Pagnini et al. (2016)^[@bibr34-0269216317709965]^      Italy             Longitudinal (4 months)                                                         114 (70)                                                             82.3                        57 (13.5)                            32 (50.3), d                                                         30.6 (9.9)

  Qutub et al. (2014)^[@bibr23-0269216317709965]^        USA               Cross-sectional                                                                 50 (66)                                                              n.r.                        61 (n.r.)                            37 (n.r.), o                                                         34.10 (n.r)^[R](#table-fn1-0269216317709965){ref-type="table-fn"}^

  Rabkin et al. (2000)^[@bibr11-0269216317709965]^       USA               Cross-sectional                                                                 31 (61)                                                              96.7                        53 (12.0)                            14 (n.r.), d                                                         30.4 (4.7)

  Rabkin et al. (2009)^[@bibr35-0269216317709965]^       USA               Longitudinal (monthly)^[c](#table-fn4-0269216317709965){ref-type="table-fn"}^   71 (74)                                                              63.0                        57 (15.0)                            n.r.                                                                 23.6 (7.8)^[R](#table-fn1-0269216317709965){ref-type="table-fn"}^

  Tramonti et al. (2014)^[@bibr36-0269216317709965]^     Italy             Longitudinal (6 months)                                                         19 (68)                                                              68.4                        53 (11.6)                            \<6, d                                                               18.2 (12.0)

  Tramonti et al. (2015)^[@bibr37-0269216317709965]^     Italy             Cross-sectional                                                                 70 (69)                                                              71.4                        54 (11.5)                            n.r.                                                                 n.r.

  Tremolizzo et al. (2016)^[@bibr38-0269216317709965]^   Italy             Cross-sectional                                                                 84 (75)                                                              78.0                        n.r.                                 40 (37.5), n.r.                                                      30.6 (9.0)^[R](#table-fn1-0269216317709965){ref-type="table-fn"}^

  Watermeyer et al. (2015)^[@bibr39-0269216317709965]^   UK                Cross-sectional                                                                 35 (72)                                                              100                         58 (10.5)                            30 (14.3), o                                                         34.1 (8.2)^[R](#table-fn1-0269216317709965){ref-type="table-fn"}^
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

ALSFRS: Amyotrophic Lateral Sclerosis Functioning Rating Scale \[total score range 0--40 (better functioning)\]; d: time since diagnosis; n.r.: not reported; o: time since disease onset; ^R^: Amyotrophic Lateral Sclerosis Functioning Rating Scale Revised \[total score range 0--48 (better functioning)\]; SD: standard deviation; \*: median.

Design of caregiver study.

Not consistently reported.

Only cross-sectional data with regard to burden was analyzed.

Measures of burden {#section20-0269216317709965}
------------------

Across studies, five different validated measures of caregiver burden were used (Zarit Burden Interview (*n* = 11),^[@bibr40-0269216317709965]^ Caregiver Burden Inventory (*n* = 6),^[@bibr41-0269216317709965]^ Caregiver Strain Index (*n* = 2),^[@bibr42-0269216317709965]^ Burden Scale for Family Caregivers (*n* = 1),^[@bibr43-0269216317709965]^ and Caregiver Burden Scale (*n* = 1))^[@bibr44-0269216317709965]^ and two studies used a number of selected items of the Zarit Burden Interview (see Supplementary Appendix 6). Two studies used a single-item measurement to measure burden.^[@bibr45-0269216317709965]^

Studied factors in relation to caregiver burden in ALS caregivers {#section21-0269216317709965}
-----------------------------------------------------------------

Overviews of the studied caregiver and patient factors that were investigated in relation to caregiver burden are presented in [Tables 2](#table2-0269216317709965){ref-type="table"} and [3](#table3-0269216317709965){ref-type="table"}. Caregiver factors were grouped into the following categories: emotional functioning, social environment, demographics, personal factors, physical health, and caregiving time. Patient factors were categorized into physical health, behavioral impairments, cognitive impairments, emotional functioning, personal factors, demographics, and social environment.

###### 

Associations between caregiver factors and caregiver burden.

![](10.1177_0269216317709965-table2)

                          Factor^[a](#table-fn6-0269216317709965){ref-type="table-fn"}^   Measure factor                   Outcome caregiver burden   Bivariate association                                             Bivariate analysis   Multivariate association                                                                                                          *N*   Ref
  ----------------------- --------------------------------------------------------------- -------------------------------- -------------------------- ----------------------------------------------------------------- -------------------- --------------------------------------------------------------------------------------------------------------------------------- ----- ----------------------------
  Emotional functioning   Feelings of depression                                          BDI                              ZBI-6 items                0.49[\*](#table-fn7-0269216317709965){ref-type="table-fn"}        P                    --                                                                                                                                31    [@bibr11-0269216317709965]
                                                                                          BDI                              CBI                        0.51[\*\*\*](#table-fn7-0269216317709965){ref-type="table-fn"}    P                    --                                                                                                                                82    [@bibr38-0269216317709965]
                                                                                          BDI-II                           ZBI                        0.43[\*\*](#table-fn7-0269216317709965){ref-type="table-fn"}      P                    --                                                                                                                                40    [@bibr21-0269216317709965]
                                                                                          BDI-II                           ZBI                        +n.r.[\*\*\*](#table-fn7-0269216317709965){ref-type="table-fn"}   R                    --                                                                                                                                50    [@bibr23-0269216317709965]
                                                                                          ZDS                              CBI                        0.55[\*\*\*](#table-fn7-0269216317709965){ref-type="table-fn"}    S                    +n.r.[\*\*\*](#table-fn7-0269216317709965){ref-type="table-fn"} (n.r.)                                                            60    [@bibr10-0269216317709965]
                                                                                          ZDS                              CBI                        --                                                                --                   n.r.[\*](#table-fn7-0269216317709965){ref-type="table-fn"} (n.r.)                                                                 70    [@bibr27-0269216317709965]
                                                                                          ZDS                              CBI                        n.r.[\*](#table-fn7-0269216317709965){ref-type="table-fn"}        n.r.                 --                                                                                                                                31    [@bibr6-0269216317709965]
                                                                                          ZDS (t1)                         CBI (t1)                   n.r.[\*](#table-fn7-0269216317709965){ref-type="table-fn"}        n.r.                 --                                                                                                                                31    [@bibr6-0269216317709965]
                                                                                          HADS-Depression (t0--t3)         CSI (t0--t3)               --                                                                --                   ns                                                                                                                                116   [@bibr5-0269216317709965]
                                                                                          HADS-Depression                  ZBI                        0.57[\*\*\*](#table-fn7-0269216317709965){ref-type="table-fn"}    P                    ns                                                                                                                                35    [@bibr39-0269216317709965]
                                                                                          DASS-Depression                  ZBI-sv                     --                                                                --                   ns^[or](#table-fn5-0269216317709965){ref-type="table-fn"}^                                                                        140   [@bibr32-0269216317709965]
                          Depression-Somatic                                              BDI-II-Somatic                   ZBI                        0.84[\*\*\*](#table-fn7-0269216317709965){ref-type="table-fn"}    S                    --                                                                                                                                40    [@bibr22-0269216317709965]
                          Depression-Psychological                                        BDI-II-Psychological             ZBI                        0.57[\*](#table-fn7-0269216317709965){ref-type="table-fn"}        S                    --                                                                                                                                40    [@bibr22-0269216317709965]
                          Feelings of anxiety                                             HADS-Anxiety                     ZBI                        0.37[\*](#table-fn7-0269216317709965){ref-type="table-fn"}        P                    ns                                                                                                                                35    [@bibr39-0269216317709965]
                                                                                          HADS-Anxiety (t0--t3)            CSI (t0--t3)               --                                                                --                   0.19[\*\*\*](#table-fn7-0269216317709965){ref-type="table-fn"} (0.086, 0.286)                                                     116   [@bibr5-0269216317709965]
                                                                                          DASS-Anxiety                     ZBI-sv                     --                                                                                     ns^[or](#table-fn5-0269216317709965){ref-type="table-fn"}^                                                                        140   [@bibr32-0269216317709965]
                                                                                          STAI-Trait                       ZBI                        0.36[\*](#table-fn7-0269216317709965){ref-type="table-fn"}        P                    --                                                                                                                                40    [@bibr21-0269216317709965]
                                                                                          STAI-Trait                       ZBI-6 items                0.40^n.r.^                                                        P                    --                                                                                                                                31    [@bibr11-0269216317709965]
                          Distress                                                        HADS-Total                       ZBI                        0.62[\*\*\*](#table-fn7-0269216317709965){ref-type="table-fn"}    R                    --                                                                                                                                33    [@bibr26-0269216317709965]
                                                                                          HADS-Total                       ZBI                        --                                                                --                   +n.r.[\*\*](#table-fn7-0269216317709965){ref-type="table-fn"} (n.r.)                                                              81    [@bibr28-0269216317709965]
                                                                                          DASS-Stress                      ZBI-sv                     --                                                                --                   1.12^[or](#table-fn5-0269216317709965){ref-type="table-fn"}^[\*](#table-fn7-0269216317709965){ref-type="table-fn"} (0.86, 1.00)   140   [@bibr32-0269216317709965]
                          Mental health                                                   SF-36-MCS                        CSI                        0.50[\*\*\*](#table-fn7-0269216317709965){ref-type="table-fn"}    n.r.                 --                                                                                                                                415   [@bibr31-0269216317709965]
                          Hopelessness                                                    BHS                              ZBI-6 items                ns                                                                P                    --                                                                                                                                31    [@bibr11-0269216317709965]
  Social environment      Social support                                                  MQoL-Ss                          ZBI                        −0.73[\*\*\*](#table-fn7-0269216317709965){ref-type="table-fn"}   S                    --                                                                                                                                40    [@bibr22-0269216317709965]
                                                                                          5-point scale                    ZBI                        ns                                                                P                    --                                                                                                                                31    [@bibr11-0269216317709965]
                                                                                          No. of friends/relatives seen    Strain Index               ns                                                                S                    --                                                                                                                                19    [@bibr19-0269216317709965]
                                                                                          No. of close friends             Strain Index               ns                                                                S                    --                                                                                                                                19    [@bibr19-0269216317709965]
                                                                                          No. of friends that can help     Strain Index               ns                                                                S                    --                                                                                                                                19    [@bibr19-0269216317709965]
                                                                                          No. of substitute cgs            CBI                        ns                                                                S                    --                                                                                                                                60    [@bibr10-0269216317709965]
                                                                                          Participating in support group   BSFC                       ns                                                                S                    --                                                                                                                                37    [@bibr30-0269216317709965]
                                                                                          Participating in support group   CBI                        ns                                                                S                    --                                                                                                                                60    [@bibr10-0269216317709965]
                                                                                          Outside help received            ZBI                        ns                                                                R                    --                                                                                                                                50    [@bibr23-0269216317709965]
                                                                                          Hours per week help              ZBI                        ns                                                                R                    --                                                                                                                                50    [@bibr23-0269216317709965]
                          Family functioning                                              FACES-Real cohesion              CBI                        ns                                                                S                    --                                                                                                                                19    [@bibr36-0269216317709965]
                                                                                          FACES-Real cohesion (t0)         CBI (t1)                   --                                                                --                   0.53[\*](#table-fn7-0269216317709965){ref-type="table-fn"} (n.r.)                                                                 19    [@bibr36-0269216317709965]
                                                                                          FACES-Ideal cohesion             CBI                        ns                                                                S                    --                                                                                                                                19    [@bibr36-0269216317709965]
                                                                                          FACES-Real adaptability          CBI                        ns                                                                S                    --                                                                                                                                19    [@bibr36-0269216317709965]
                                                                                          FACES-Ideal adaptability         CBI                        ns                                                                S                    --                                                                                                                                19    [@bibr36-0269216317709965]
                                                                                          MIS                              ZBI                        −0.45[\*\*](#table-fn7-0269216317709965){ref-type="table-fn"}     P                    ns                                                                                                                                35    [@bibr39-0269216317709965]
                                                                                          MIS (change)                     ISS-1                      0.50[\*](#table-fn7-0269216317709965){ref-type="table-fn"}        n.r.                 --                                                                                                                                19    [@bibr20-0269216317709965]
                          Quality of care cgs                                             Numerical scale (t0--t3)         CSI (t0--t3)               --                                                                --                   −0.45[\*\*\*](#table-fn7-0269216317709965){ref-type="table-fn"} (−0.672, −0.232)                                                  116   [@bibr5-0269216317709965]
  Demographics            Age                                                             Years                            CBI                        ns                                                                S                    --                                                                                                                                60    [@bibr10-0269216317709965]
                                                                                          Years                            CBI                        ns                                                                n.r.                 --                                                                                                                                31    [@bibr6-0269216317709965]
                                                                                          Years                            CBI                        0.24[\*](#table-fn7-0269216317709965){ref-type="table-fn"}        S                    --                                                                                                                                70    [@bibr37-0269216317709965]
                                                                                          Years                            ZBI                        ns                                                                P                    --                                                                                                                                35    [@bibr39-0269216317709965]
                                                                                          Years                            ZBI                        --                                                                --                   ns                                                                                                                                81    [@bibr28-0269216317709965]
                                                                                          Years                            ZBI                        −n.r.[\*\*](#table-fn7-0269216317709965){ref-type="table-fn"}     R                    --                                                                                                                                50    [@bibr23-0269216317709965]
                                                                                          Years                            ZBI                        --                                                                --                   0.19[\*](#table-fn7-0269216317709965){ref-type="table-fn"} (n.r.)                                                                 81    [@bibr29-0269216317709965]
                          Gender                                                          Male/female                      CBI                        ns                                                                n.r.                 --                                                                                                                                31    [@bibr6-0269216317709965]
                                                                                          Male/female                      ZBI                        --                                                                --                   ns                                                                                                                                81    [@bibr28-0269216317709965]
                          Years married                                                   Years                            ZBI                        ns                                                                P                    --                                                                                                                                35    [@bibr39-0269216317709965]
                          Relationship patient                                            Spouse/child/parent/..           ZBI                        --                                                                --                   ns                                                                                                                                81    [@bibr28-0269216317709965]
                          Living with patient                                             Yes/no                           ZBI                        --                                                                --                   ns                                                                                                                                81    [@bibr28-0269216317709965]
                          Household income                                                Dollars                          ZBI                        ns                                                                R                    --                                                                                                                                50    [@bibr23-0269216317709965]
  Personal factors        State of mindfulness                                            LMS                              ZBI                        −0.27[\*\*](#table-fn7-0269216317709965){ref-type="table-fn"}     P                    --                                                                                                                                140   [@bibr34-0269216317709965]
                                                                                          LMS (t1)                         ZBI (t1)                   −0.29[\*](#table-fn7-0269216317709965){ref-type="table-fn"}       P                    --                                                                                                                                140   [@bibr34-0269216317709965]
                                                                                          LMS (t0 + t1)                    ZBI (t0 + t1)              --                                                                --                   −n.r.[\*](#table-fn7-0269216317709965){ref-type="table-fn"} (n.r.)                                                                140   [@bibr34-0269216317709965]
                          Religiosity                                                     RBI                              ZBI-6 items                ns                                                                P                    --                                                                                                                                31    [@bibr11-0269216317709965]
                                                                                          Not-very religious               ZBI                        ns                                                                R                    --                                                                                                                                50    [@bibr23-0269216317709965]
                          Positive meaning in caring                                      FM-4 items                       ZBI-6 items                0.49[\*\*](#table-fn7-0269216317709965){ref-type="table-fn"}      P                    --                                                                                                                                31    [@bibr11-0269216317709965]
                          Passive coping                                                  UCL-PA (t0--t3)                  CSI (t0--t3)               --                                                                                     0.15[\*](#table-fn7-0269216317709965){ref-type="table-fn"} (0.015, 0.289)                                                         116   [@bibr5-0269216317709965]
                          Illness affects life areas                                      ISS-4                            ISS-1                      0.50[\*](#table-fn7-0269216317709965){ref-type="table-fn"}        n.r.                 --                                                                                                                                19    [@bibr20-0269216317709965]
                          Attribution style                                               Globality attribution measure    Strain Index               0.58[\*\*](#table-fn7-0269216317709965){ref-type="table-fn"}      S                    --                                                                                                                                19    [@bibr19-0269216317709965]
                          Control over reactions                                          Control over reactions measure   Strain Index               −n.r.[\*](#table-fn7-0269216317709965){ref-type="table-fn"}       S                    --                                                                                                                                19    [@bibr19-0269216317709965]
  Physical health         Physical functioning                                            SF-36-PCS                        CSI                        0.28[\*\*\*](#table-fn7-0269216317709965){ref-type="table-fn"}    n.r.                 --                                                                                                                                415   [@bibr31-0269216317709965]
                          Physical fatigue                                                CFS-physical fatigue             ZBI-6 items                0.36^n.r.^                                                        P                    --                                                                                                                                31    [@bibr11-0269216317709965]
  Caregiving time         Time caring                                                     Hours per day                    ZBI                        ns                                                                R                    --                                                                                                                                33    [@bibr26-0269216317709965]
                                                                                          Hours per week                   ZBI                        --                                                                                     n.r.[\*](#table-fn7-0269216317709965){ref-type="table-fn"} (n.r.)                                                                 81    [@bibr28-0269216317709965]
                                                                                          Hours per day                    ZBI                        +n.r.[\*](#table-fn7-0269216317709965){ref-type="table-fn"}       R                    --                                                                                                                                50    [@bibr23-0269216317709965]
                                                                                          Time with patient                Hours per day              ZBI                                                               ns                   --                                                                                                                                50    [@bibr23-0269216317709965]
                                                                                          \% time caring                   \% time of day             ZBI                                                               ns                   --                                                                                                                                50    [@bibr23-0269216317709965]

BDI: Beck Depression Inventory; BHS: Beck Hopelessness Scale; BSFC: Burden Scale for Family Caregivers; CBI: Caregiver Burden Inventory; CFS-physical fatigue: Chalder Fatigue Scale, Physical Fatigue subscale; cgs: caregivers; CI: confidence interval; CSI: Caregiver Strain Index; DASS: Depression, Anxiety, Stress Scale; FACES: Family Adaptation and Cohesion Evaluation Scale; FM: Folkman's 4-item measure of finding positive meaning in caregiving; HADS: Hospital Anxiety and Depression Scale; ISS: Item Strain Scale; LMS: Langer Mindfulness Scale; MIS: Marital Intimacy Scale; MQoL-Ss: McGill Quality of Life social support subscale; n.r.: not reported; no.: number; ns: not significant; ^or^: odds ratio; P: Pearson's product moment correlation; R: univariate regression analysis; RBI: Religious Beliefs Inventory; S: Spearman's rank order correlation; SF-36: 36-item Short Form Health Survey Questionnaire; SF-36-MCS: 36-item Short Form Health Survey Questionnaire Mental Component; SF-36-PCS: 36-item Short Form Health Survey Questionnaire Physical Component; STAI: State-Trait Anxiety Inventory; UCL-PA: Utrecht Coping List Passive Approach subscale; ZBI: Zarit Burden Interview; ZBI-sv: Zarit Burden Interview-short version; ZDS: Zung Depression Scale.

Factors and outcomes are measured at t0 unless mentioned otherwise.

*p* \< 0.05; \*\**p* \< 0.01; \*\*\**p* \< 0.001.

###### 

Associations between patient factors and caregiver burden.

![](10.1177_0269216317709965-table3)

                           Factor^[a](#table-fn9-0269216317709965){ref-type="table-fn"}^   Measure factor                                                              Outcome caregiver burden   Bivariate association                                                        Bivariate analysis   Multivariate association                                                                                                             *N*   Ref
  ------------------------ --------------------------------------------------------------- --------------------------------------------------------------------------- -------------------------- ---------------------------------------------------------------------------- -------------------- ------------------------------------------------------------------------------------------------------------------------------------ ----- ----------------------------
  Physical health          Physical functioning                                            ALSFRS                                                                      CBI                        −0.61[\*\*\*](#table-fn11-0269216317709965){ref-type="table-fn"}             S                    −n.r.[\*\*\*](#table-fn11-0269216317709965){ref-type="table-fn"} (n.r.)                                                              60    [@bibr10-0269216317709965]
  ALSFRS                   CBI                                                             −0.61[\*\*\*](#table-fn11-0269216317709965){ref-type="table-fn"}            n.r.                       --                                                                           31                   [@bibr6-0269216317709965]                                                                                                                  
  ALSFRS (t1)              CBI (t1)                                                        −0.64[\*\*\*](#table-fn11-0269216317709965){ref-type="table-fn"}            n.r.                       --                                                                           31                   [@bibr6-0269216317709965]                                                                                                                  
  ALSFRS                   CBI                                                             −0.44[\*\*](#table-fn11-0269216317709965){ref-type="table-fn"}              S                          --                                                                           70                   [@bibr37-0269216317709965]                                                                                                                 
  ALSFRS-R                 CBI                                                             −0.52[\*\*\*](#table-fn11-0269216317709965){ref-type="table-fn"}            P                          --                                                                           84                   [@bibr38-0269216317709965]                                                                                                                 
  ALSFRS                   BSFC                                                            −0.47[\*\*](#table-fn11-0269216317709965){ref-type="table-fn"}              S                          --                                                                           37                   [@bibr30-0269216317709965]                                                                                                                 
  ALSFRS-R                 ZBI                                                             −0.46[\*](#table-fn11-0269216317709965){ref-type="table-fn"}                S                          --                                                                           40                   [@bibr22-0269216317709965]                                                                                                                 
  ALSFRS-R                 ZBI                                                             ns                                                                          R                          --                                                                           33                   [@bibr26-0269216317709965]                                                                                                                 
  ALSFRS-R                 ZBI                                                             ns                                                                          S                          --                                                                           40                   [@bibr24-0269216317709965]                                                                                                                 
  ALSFRS-R                 ZBI                                                             ns                                                                          R                          --                                                                           50                   [@bibr23-0269216317709965]                                                                                                                 
  ALSFRS-R                 ZBI-5 items                                                     ns                                                                          P                          --                                                                           71                   [@bibr35-0269216317709965]                                                                                                                 
  ALSFRS-R                 CGBS                                                            --                                                                          --                         −0.58[\*](#table-fn11-0269216317709965){ref-type="table-fn"} (−1.1, −0.01)   86                   [@bibr25-0269216317709965]                                                                                                                 
                                                                                           ALSFRS-R (t0--t3)                                                           CSI (t0--t3)               --                                                                           --                   −0.13[\*\*\*](#table-fn11-0269216317709965){ref-type="table-fn"} (−0.170, −0.092)                                                    116   [@bibr5-0269216317709965]
                           Bulbar function                                                 ALSFRS-Bulbar                                                               CBI                        ns                                                                           n.r.                 --                                                                                                                                   31    [@bibr6-0269216317709965]
                                                                                           ALSFRS-Bulbar                                                               ZBI-sv                     --                                                                           --                   ns^[or](#table-fn8-0269216317709965){ref-type="table-fn"}^                                                                           140   [@bibr32-0269216317709965]
                                                                                           ALSFRS-R-Bulbar                                                             ZBI                        ns                                                                           P                    --                                                                                                                                   35    [@bibr39-0269216317709965]
                           Motor function                                                  ALSFRS-R-Limb                                                               ZBI                        −0.66[\*\*\*](#table-fn11-0269216317709965){ref-type="table-fn"}             P                    −0.51[\*\*](#table-fn11-0269216317709965){ref-type="table-fn"} (n.r.)                                                                35    [@bibr39-0269216317709965]
                                                                                           ALSFRS-R-Upper limb                                                         CBI                        n.r.[\*](#table-fn11-0269216317709965){ref-type="table-fn"}                  n.r.                 --                                                                                                                                   31    [@bibr6-0269216317709965]
                                                                                           ALSFRS-Lower limb                                                           CBI                        n.r.[\*](#table-fn11-0269216317709965){ref-type="table-fn"}                  n.r.                 --                                                                                                                                   31    [@bibr6-0269216317709965]
                                                                                           ALSFRS-Fine motor                                                           ZBI-sv                     --                                                                           --                   ns^[or](#table-fn8-0269216317709965){ref-type="table-fn"}^                                                                           140   [@bibr32-0269216317709965]
                                                                                           ALSFRS-Gross motor                                                          ZBI-sv                     --                                                                           --                   ns^[or](#table-fn8-0269216317709965){ref-type="table-fn"}^                                                                           140   [@bibr32-0269216317709965]
                                                                                           ALSFRS-R Fine & Gross                                                       ZBI                        --                                                                           --                   −0.52[\*\*\*](#table-fn11-0269216317709965){ref-type="table-fn"} (n.r.)                                                              81    [@bibr29-0269216317709965]
                           Respiratory function                                            ALSFRS-Respiration                                                          CBI                        ns                                                                           n.r.                 --                                                                                                                                   31    [@bibr6-0269216317709965]
                                                                                           ALSFRS-Respiration                                                          ZBI-sv                     --                                                                           --                   ns^[or](#table-fn8-0269216317709965){ref-type="table-fn"}^                                                                           140   [@bibr32-0269216317709965]
                                                                                           ALSFRS-R-Respiration                                                        ZBI                        ns                                                                           P                    --                                                                                                                                   35    [@bibr39-0269216317709965]
                                                                                           FVC                                                                         ZBI                        −0.42[\*\*](#table-fn11-0269216317709965){ref-type="table-fn"}               P                    --                                                                                                                                   40    [@bibr21-0269216317709965]
                                                                                           PCF                                                                         ZBI                        −0.35[\*](#table-fn11-0269216317709965){ref-type="table-fn"}                 P                    --                                                                                                                                   40    [@bibr21-0269216317709965]
                           Disease progression                                             Progression index^[b](#table-fn10-0269216317709965){ref-type="table-fn"}^   CBI                        0.27[\*](#table-fn11-0269216317709965){ref-type="table-fn"}                  P                    --                                                                                                                                   84    [@bibr38-0269216317709965]
                           Physical health                                                 SF-36-PCS                                                                   CSI                        0.51[\*\*\*](#table-fn11-0269216317709965){ref-type="table-fn"}              n.r.                 --                                                                                                                                   415   [@bibr31-0269216317709965]
                           Self care                                                       CBI-R-Self care                                                             ZBI                        ns                                                                           S                    --                                                                                                                                   40    [@bibr24-0269216317709965]
                           Everyday skills                                                 CBI-R-Everyday skills                                                       ZBI                        0.41[\*\*](#table-fn11-0269216317709965){ref-type="table-fn"}                S                    --                                                                                                                                   40    [@bibr24-0269216317709965]
                           Disease duration                                                Years                                                                       CBI                        --                                                                           --                   n.r.[\*](#table-fn11-0269216317709965){ref-type="table-fn"} (n.r.)                                                                   60    [@bibr10-0269216317709965]
                                                                                           Months                                                                      ZBI                        ns                                                                           P                    --                                                                                                                                   35    [@bibr39-0269216317709965]
                                                                                           Months                                                                      CBI                        ns                                                                           P                    --                                                                                                                                   84    [@bibr38-0269216317709965]
  Behavioral impairments   Behavioral impairments                                          FrSBe-Total                                                                 CBI                        0.38[\*\*\*](#table-fn11-0269216317709965){ref-type="table-fn"}              P                    +n.r.[\*](#table-fn11-0269216317709965){ref-type="table-fn"} (n.r.)                                                                  70    [@bibr27-0269216317709965]
                                                                                           FrSBe-Total                                                                 ZBI                        0.69[\*\*\*](#table-fn11-0269216317709965){ref-type="table-fn"}              P                    0.69[\*\*](#table-fn11-0269216317709965){ref-type="table-fn"} (n.r.)                                                                 35    [@bibr39-0269216317709965]
                                                                                           CBI-R-Total                                                                 ZBI                        0.66[\*\*\*](#table-fn11-0269216317709965){ref-type="table-fn"}              S                    --                                                                                                                                   40    [@bibr24-0269216317709965]
                                                                                           FrSBe-Total (change)                                                        ZBI                        0.56[\*](#table-fn11-0269216317709965){ref-type="table-fn"}                  R                    --                                                                                                                                   33    [@bibr26-0269216317709965]
                                                                                           ALS-CBS-Behavior                                                            CGBS                       −0.76[\*\*\*](#table-fn11-0269216317709965){ref-type="table-fn"}             R                    −0.69[\*\*\*](#table-fn11-0269216317709965){ref-type="table-fn"} (−0.98, −0.41)                                                      86    [@bibr25-0269216317709965]
                                                                                           ALS-CBS-Behavior                                                            CBI                        −0.22[\*](#table-fn11-0269216317709965){ref-type="table-fn"}                 P                    −n.r.[\*](#table-fn11-0269216317709965){ref-type="table-fn"} (n.r.)                                                                  84    [@bibr38-0269216317709965]
                           Apathy                                                          FrSBe-Apathy                                                                ZBI                        0.63[\*\*\*](#table-fn11-0269216317709965){ref-type="table-fn"}              P                    ns                                                                                                                                   35    [@bibr39-0269216317709965]
                                                                                           FrSBe-Apathy (change)                                                       ZBI                        0.39[\*](#table-fn11-0269216317709965){ref-type="table-fn"}                  R                    --                                                                                                                                   33    [@bibr26-0269216317709965]
                           Disinhibition                                                   FrSBe-Disinhibition                                                         CBI                        ns                                                                           P                    --                                                                                                                                   70    [@bibr27-0269216317709965]
                                                                                           FrSBe-Disinhibition                                                         ZBI                        0.51[\*\*](#table-fn11-0269216317709965){ref-type="table-fn"}                P                    ns                                                                                                                                   35    [@bibr39-0269216317709965]
                                                                                           FrSBe-Disinhibition (change)                                                ZBI                        0.53[\*\*](#table-fn11-0269216317709965){ref-type="table-fn"}                R                    --                                                                                                                                   33    [@bibr26-0269216317709965]
                           Executive functioning                                           FrSBe-Executive dysfunction                                                 CBI                        0.44[\*\*\*](#table-fn11-0269216317709965){ref-type="table-fn"}              P                    ns                                                                                                                                   70    [@bibr27-0269216317709965]
                                                                                           FrSBe-Executive dysfunction                                                 ZBI                        0.51[\*\*](#table-fn11-0269216317709965){ref-type="table-fn"}                P                    ns                                                                                                                                   35    [@bibr39-0269216317709965]
                                                                                           FrSBe-Executive dysfunction (change)                                        ZBI                        0.37[\*](#table-fn11-0269216317709965){ref-type="table-fn"}                  R                    --                                                                                                                                   33    [@bibr26-0269216317709965]
                                                                                           Battery of tests                                                            ZBI                        ns                                                                           P                    --                                                                                                                                   35    [@bibr39-0269216317709965]
                           Behavior abnormalities                                          CBI-R-Abnormal behavior                                                     ZBI-sv                     --                                                                           --                   1.44^[or](#table-fn8-0269216317709965){ref-type="table-fn"}^[\*\*](#table-fn11-0269216317709965){ref-type="table-fn"} (1.13, 1.85)   140   [@bibr32-0269216317709965]
                                                                                           CBI-R-Abnormal behavior                                                     ZBI                        0.38[\*](#table-fn11-0269216317709965){ref-type="table-fn"}                  S                    --                                                                                                                                   40    [@bibr24-0269216317709965]
                           Eating habits                                                   CBI-R-Eating habits                                                         ZBI-sv                     --                                                                           --                   ns^[or](#table-fn8-0269216317709965){ref-type="table-fn"}^                                                                           140   [@bibr32-0269216317709965]
                                                                                           CBI-R-Eating habits                                                         ZBI                        0.36[\*](#table-fn11-0269216317709965){ref-type="table-fn"}                  S                    --                                                                                                                                   40    [@bibr24-0269216317709965]
                           Stereotypic and motor behaviors                                 CBI-R-Stereotypical motor behavior                                          ZBI-sv                     --                                                                           --                   ns^[or](#table-fn8-0269216317709965){ref-type="table-fn"}^                                                                           140   32
                                                                                           CBI-R-Stereotypical motor behavior                                          ZBI                        0.32[\*](#table-fn11-0269216317709965){ref-type="table-fn"}                  S                    --                                                                                                                                   40    [@bibr24-0269216317709965]
                           Motivation                                                      CBI-R-Lack of motivation                                                    ZBI-sv                     --                                                                           --                   ns^[or](#table-fn8-0269216317709965){ref-type="table-fn"}^                                                                           140   [@bibr32-0269216317709965]
                                                                                           CBI-R-Lack of motivation                                                    ZBI                        0.43[\*\*](#table-fn11-0269216317709965){ref-type="table-fn"}                S                    --                                                                                                                                   40    [@bibr24-0269216317709965]
                           Odd beliefs                                                     CBI-R-Odd beliefs                                                           ZBI                        ns                                                                           S                    --                                                                                                                                   40    [@bibr24-0269216317709965]
  Cognitive impairments    Overall cognitive functioning                                   Neuropsychological tests                                                    ZBI                        ns                                                                           R                    --                                                                                                                                   33    [@bibr26-0269216317709965]
                                                                                           MMSE                                                                        CBI                        ns                                                                           P                    --                                                                                                                                   84    [@bibr38-0269216317709965]
                                                                                           FAB                                                                         CBI                        ns                                                                           P                    --                                                                                                                                   84    [@bibr38-0269216317709965]
                                                                                           ALS-CBS-Cognition                                                           CBI                        ns                                                                           P                    --                                                                                                                                   84    [@bibr38-0269216317709965]
                                                                                           ALS-CBS-Cognition                                                           CGBS                       −1.4[\*](#table-fn11-0269216317709965){ref-type="table-fn"}                  R                    −1.42[\*](#table-fn11-0269216317709965){ref-type="table-fn"} (−2.8, −0.05)                                                           86    [@bibr25-0269216317709965]
                           Attention                                                       ALS-CBS-Attention                                                           CGBS                       −0.25[\*](#table-fn11-0269216317709965){ref-type="table-fn"}                 R                    --                                                                                                                                   86    [@bibr25-0269216317709965]
                           Concentration                                                   ALS-CBS-Concentration                                                       CGBS                       −0.25[\*](#table-fn11-0269216317709965){ref-type="table-fn"}                 R                    --                                                                                                                                   86    [@bibr25-0269216317709965]
                           Fluency                                                         ALS-CBS-Fluency                                                             CGBS                       ns                                                                           R                    --                                                                                                                                   86    [@bibr25-0269216317709965]
                           Memory/orientation                                              CBI-R Memory/orientation                                                    ZBI                        0.63[\*\*\*](#table-fn11-0269216317709965){ref-type="table-fn"}              S                    --                                                                                                                                   40    [@bibr24-0269216317709965]
                           Executive functioning                                           WST                                                                         CBI                        ns                                                                           P                    --                                                                                                                                   84    [@bibr38-0269216317709965]
                           Social cognition                                                Battery of tests                                                            ZBI                        ns                                                                           P                    --                                                                                                                                   35    [@bibr39-0269216317709965]
  Emotional functioning    Feelings of depression                                          HADS-Depression (t0--t3)                                                    CSI (t0--t3)               --                                                                           --                   ns                                                                                                                                   116   [@bibr5-0269216317709965]
                                                                                           HADS-R-Depression                                                           ZBI                        ns                                                                           P                    --                                                                                                                                   35    [@bibr39-0269216317709965]
                                                                                           BDI                                                                         CBI                        ns                                                                           P                    --                                                                                                                                   79    [@bibr38-0269216317709965]
                           Anxiety                                                         HADS-R-Anxiety                                                              ZBI                        ns                                                                           P                    --                                                                                                                                   35    [@bibr39-0269216317709965]
                           Emotional functioning                                           ALSAQ-40Se (t0--t3)                                                         CSI (t0--t3)               --                                                                           --                   0.02[\*](#table-fn11-0269216317709965){ref-type="table-fn"} (0.022, 0.042)                                                           116   [@bibr5-0269216317709965]
                           Lability                                                        ELQ                                                                         ZBI                        ns                                                                           P                    --                                                                                                                                   35    [@bibr39-0269216317709965]
                           Mental health                                                   SF-36-MCS                                                                   CSI                        0.28[\*\*\*](#table-fn11-0269216317709965){ref-type="table-fn"}              n.r.                 --                                                                                                                                   415   [@bibr31-0269216317709965]
                           Mood                                                            CBI-R-Mood                                                                  ZBI                        0.38[\*](#table-fn11-0269216317709965){ref-type="table-fn"}                  S                    --                                                                                                                                   40    [@bibr24-0269216317709965]
  Personal factors         Existential well-being                                          MQol-Ewbs                                                                   ZBI                        −0.60[\*\*\*](#table-fn11-0269216317709965){ref-type="table-fn"}             P                    --                                                                                                                                   37    [@bibr33-0269216317709965]
                           Religion is source of strength                                  ALSSQoL-R statement (0--10)                                                 ZBI                        −0.43[\*\*\*](#table-fn11-0269216317709965){ref-type="table-fn"}             P                    --                                                                                                                                   37    [@bibr33-0269216317709965]
                           Consider self as religious/spiritual                            ALSSQoL-R statement (0--10)                                                 ZBI                        −0.49[\*\*\*](#table-fn11-0269216317709965){ref-type="table-fn"}             P                    --                                                                                                                                   37    [@bibr33-0269216317709965]
                           Self perceived as burden                                        SPBS                                                                        CBI                        0.33[\*](#table-fn11-0269216317709965){ref-type="table-fn"}                  S                    ns                                                                                                                                   60    [@bibr10-0269216317709965]
                                                                                           SPBS                                                                        CBI                        0.41[\*](#table-fn11-0269216317709965){ref-type="table-fn"}                  n.r.                 --                                                                                                                                   31    [@bibr6-0269216317709965]
                                                                                           SPBS (t1)                                                                   CBI (t1)                   0.38[\*](#table-fn11-0269216317709965){ref-type="table-fn"}                  n.r.                 --                                                                                                                                   31    [@bibr6-0269216317709965]
                           Burden cg rated by patient                                      Visual analogue scale                                                       ZBI-5 items                0.29[\*](#table-fn11-0269216317709965){ref-type="table-fn"}                  P                    --                                                                                                                                   71    [@bibr35-0269216317709965]
                           Active coping                                                   UCL-AA (t0--t3)                                                             CSI (t0--t3)               --                                                                           --                   ns                                                                                                                                   116   [@bibr5-0269216317709965]
  Demographics             Age                                                             Years                                                                       ZBI                        ns                                                                           R                    --                                                                                                                                   33    [@bibr26-0269216317709965]
                                                                                           Years                                                                       ZBI                        0.35[\*](#table-fn11-0269216317709965){ref-type="table-fn"}                  P                    ns                                                                                                                                   35    [@bibr39-0269216317709965]
                                                                                           Years                                                                       CSI (t0--t3)               --                                                                           --                   ns                                                                                                                                   116   [@bibr5-0269216317709965]
                           Gender                                                          Male/female                                                                 ZBI                        ns                                                                           R                    --                                                                                                                                   33    [@bibr26-0269216317709965]
                                                                                           Male/female                                                                 CGBS                       --                                                                           --                   8.1[\*](#table-fn11-0269216317709965){ref-type="table-fn"} (1.0, 15.2)                                                               86    [@bibr25-0269216317709965]
  Social environment       Social support                                                  MQoL-Ss                                                                     ZBI                        −0.53[\*\*](#table-fn11-0269216317709965){ref-type="table-fn"}               P                    --                                                                                                                                   40    [@bibr21-0269216317709965]
                           Quality of care                                                 n.r. (t0--t3)                                                               CSI (t0--t3)               --                                                                           --                   ns                                                                                                                                   116   [@bibr5-0269216317709965]
                           Family functioning                                              FACES-Ideal cohesion                                                        CBI                        −0.59[\*\*](#table-fn11-0269216317709965){ref-type="table-fn"}               S                    --                                                                                                                                   19    [@bibr36-0269216317709965]
                           Reimbursement costs care                                        Yes/no                                                                      ZBI                        --                                                                           --                   −0.19[\*](#table-fn11-0269216317709965){ref-type="table-fn"} (n.r.)                                                                  81    [@bibr29-0269216317709965]

ALSAQ-40Se: Amyotrophic Lateral Sclerosis Assessment Questionnaire 40-item subscale emotional functioning; ALS-CBS: Amyotrophic Lateral Sclerosis Cognitive-Behavioral Screen; ALSFRS: Amyotrophic Lateral Sclerosis Functional Rating Scale; ALSFRS-R: Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised; ALSSQoL-R: Amyotrophic Lateral Sclerosis Specific Quality of Life-Revised questionnaire; BDI: Beck Depression Inventory; BSFC: Burden Scale for Family Caregivers; CBI: Caregiver Burden Inventory; CBI-R: Cambridge Behavioural Inventory Revised; CGBS: Caregiver Burden Scale; CI: confidence interval; CSI: Caregiver Strain Index; ELQ: Emotional Lability Questionnaire; FAB: Frontal Assessment Battery; FACES: Family Adaptation and Cohesion Evaluation Scale; FrSBe: Frontal Systems Behavior Scale; FVC: Forced Vital Capacity; HADS: Hospital Anxiety and Depression Scale; HADS-R: Hospital Anxiety and Depression Scale Revised; MMSE: Mini-Mental State Examination; MQoL-Ewbs: McGill Quality of Life existential well-being subscale; MQoL-Ss: McGill Quality of Life social support subscale; n.r.: not reported; ns: not significant; ^or^: odds ratio; P: Pearson's product moment correlation; PCF: Peak Cough Flow; R: univariate regression analysis; S: Spearman's rank order correlation; SF-36-MCS: 36-item Short Form Health Survey Questionnaire Mental Component; SF-36-PCS: 36-item Short Form Health Survey Questionnaire Physical Component; SPBS: Self-Perceived Burden Scale; UCL-AA: Utrecht Coping List Active Approach subscale; WST: Weigl's Sorting test; ZBI: Zarit Burden Interview; ZBI-sv: Zarit Burden Interview-short version.

Factors and outcomes are measured at t0 unless mentioned otherwise.

Calculated as (\[48-ALSFRS-R\]/disease duration in months).

*p* \< 0.05; \*\**p* \< 0.01; \*\*\**p* \< 0.001.

Evidence for factors related to caregiver burden {#section22-0269216317709965}
------------------------------------------------

### Caregiver factors {#section23-0269216317709965}

The synthesis of evidence for the caregiver factors using the GRADE criteria resulted in a rating of moderate quality of evidence for the relationship between higher caregiver burden and "feelings of depression" (see [Table 4](#table4-0269216317709965){ref-type="table"}). Low quality of evidence was found for the relations between higher caregiver burden and the factors "anxiety," "distress," and "age." The social environment factors "social support" and "family functioning" showed very low quality of evidence as factors associated with lower caregiver burden.

###### 

Adapted GRADE table for narrative systematic reviews of prognostic studies.

![](10.1177_0269216317709965-table4)

  Potential factors        Participants (*n*)   No. of studies   Bivariate^[a](#table-fn13-0269216317709965){ref-type="table-fn"}^   Multivariate   Grade factors                                                
  ------------------------ -------------------- ---------------- ------------------------------------------------------------------- -------------- --------------- ---- ---- ---- ---- ---- --- --- --- --- --- ----------
  *Caregiver*                                                                                                                                                                                                    
  Feelings of depression   605                  9                5                                                                   --             --              1    1    3    --   1    ✓   ✓   ✓   ✕   ✓   Moderate
  Feelings of anxiety      362                  5                2                                                                   --             --              1    1    2    --   --   ✓   ✓   ✓   ✕   ✓   Low
  Distress                 254                  3                1                                                                   --             --              --   2    --   --   --   ✓   ✓   ✓   ✕   ✓   Low
  Social support           187                  5                --                                                                  7              1               --   --   --   --   --   ✓   ✓   ✓   ✕   ✓   Very low
  Family functioning       73                   3                --                                                                  4              2               --   1    1    --   --   ✓   ✕   ✓   ✕   ✓   Very low
  Age                      474                  7                1                                                                   3              --              --   1    2    --   --   ✓   ✓   ✓   ✕   ✓   Low
  *Patient*                                                                                                                                                                                                      
  Physical functioning     668                  11               --                                                                  3              6               --   --   --   3    --   ✓   ✓   ✓   ✕   ✓   Moderate
  Bulbar function          206                  3                --                                                                  2              --              --   --   1    --   --   ✓   ✓   ✓   ✕   ✓   Low
  Motor function           287                  4                --                                                                  --             1               2    --   2    2    --   ✓   ✓   ✓   ✕   ✓   Very low
  Respiratory function     246                  4                --                                                                  2              2               --   --   1    --   --   ✓   ✓   ✓   ✕   ✓   Very low
  Disease duration         179                  3                --                                                                  2              --              --   --   --   --   1    ✓   ✓   ✓   ✕   ✓   Very low
  Behavioral impairments   348                  6                6                                                                   --             --              --   4    --   --   --   ✓   ✓   ✓   ✕   ✓   High
  Disinhibition            138                  3                2                                                                   1              --              --   --   1    --   --   ✓   ✓   ✓   ✕   ✓   Very low
  Executive functioning    138                  3                3                                                                   1              --              --   --   2    --   --   ✓   ✓   ✓   ✕   ✓   Very low
  Cognitive functioning    203                  3                1                                                                   4              --              --   1    --   --   --   ✓   ✓   ✓   ✕   ✓   Very low
  Feelings of depression   230                  3                --                                                                  2              --              --   --   1    --   --   ✓   ✓   ✓   ✕   ✓   Low
  Age                      184                  3                1                                                                   1              --              --   --   2    --   --   ✓   ✓   ✓   ✕   ✓   Very low

For uni- and multivariate analyses: +: number of significant associations with a positive value; 0: number of non-significant associations; −: number of significant associations with a negative value; n.r.: number of associations of which the direction was not reported. For GRADE factors: ✓: no serious limitations; ✕: serious limitations. For overall quality of evidence: very low, low, moderate, high.

Bivariate associations that are measured twice in one study on different measuring points are counted as one association.

Factors within the categories personal factors, physical health of the caregiver, and caregiving time were investigated in fewer than three studies and could not, therefore, be rated with the GRADE.

### Patient factors {#section24-0269216317709965}

The synthesis of the evidence for the patient factors led to a rating of high quality evidence for the relationship between higher caregiver burden and "behavioral impairments." This factor represents total scores of questionnaires that measure behavioral impairments in patients, which was investigated in six studies. Patients' "physical functioning" was most frequently studied (*n *= 11). There was moderate quality of evidence for the relation between decreased physical functioning and higher caregiver burden. Very low quality of evidence was found for the association with higher caregiver burden and the factors "limb function," "respiratory function," "executive functioning," "cognitive functioning," and "age." Low evidence was found for "bulbar function" and "feelings of depression," and very low quality of evidence for "disease durations" as factors not associated with caregiver burden.

Since each of the factors within the categories personal factors and social environment was studied in one or two studies, no synthesis of evidence could be performed.

Discussion {#section25-0269216317709965}
==========

In our systematic review, we focused on both patient factors and caregiver factors in relation to burden in caregivers of ALS patients. Moderate to high quality of evidence was found for "behavioral impairments" of the patient, "physical functioning" of the patient, and "feelings of depression" of the caregiver as factors related to caregiver burden. These results indicate that there is a specific group of caregivers that is vulnerable to caregiver burden. For the relations between caregiver burden and the remaining caregiver and patient factors, the quality of evidence was low to very low and no general conclusions could be drawn.

We found high quality of evidence for the relation between caregiver burden and behavioral impairments of the patient. Behavioral impairments such as apathy or disinhibition occur in a substantial proportion of ALS patients and 5%--15% of patients meet the criteria for frontotemporal dementia (FTD), which is associated with more severe behavioral impairments.^[@bibr46-0269216317709965],[@bibr47-0269216317709965]^ The findings of this review highlight the impact of behavioral impairments in patients on caregiver burden, whereas cognitive impairments in patients are less likely to result in caregiver burden. This underscores the relevance of the distinction between pure ALS, ALS with behavioral impairment, ALS with cognitive impairment, and ALS with FTD.^[@bibr48-0269216317709965]^

Moderate quality of evidence was found for the relation between caregiver burden and the level of physical functioning of the patient. Caregiver burden seems to increase parallel to the disease severity of the patient, which is in line with conclusions in other progressive neurological diseases.^[@bibr49-0269216317709965],[@bibr50-0269216317709965]^ Low to very low quality of evidence was found for the relation between caregiver burden and factors measuring functioning in specific physical areas (e.g. respiratory function, motor function), indicating that burden seems to be related to the overall physical functioning but not to specific functions. The increase in burden may be the result of the fact that ALS leads to rapid decline in physical functioning, as this constantly requires physical and emotional adjustments from both patient and caregiver.^[@bibr51-0269216317709965],[@bibr52-0269216317709965]^ Furthermore, as the disease progresses, worsening of symptoms and physical concerns may lead to increased stress, worries, and burden of caregivers, taking a toll on their time and energy for leisure activities and time to fulfill their own needs.^[@bibr10-0269216317709965],[@bibr22-0269216317709965]^

Moderate quality of evidence was found for the relation between caregiver burden and feelings of depression of the caregiver; in other words, caregivers, who experience depressive symptoms, are more likely to experience high caregiver burden. This association between caregiver burden and depressive symptoms experienced by the caregiver is consistent with findings in other neurological diseases, such as dementia and stroke.^[@bibr50-0269216317709965],[@bibr53-0269216317709965]^ Caregivers who experience feelings of depression may find it even more challenging to cope with the caregiving demands placed on them, which influences caregiver burden. Although research seems to indicate that caregiver burden and depression are distinct constructs,^[@bibr54-0269216317709965],[@bibr55-0269216317709965]^ there might be conceptual overlap between the measures of depressive symptoms and caregiver burden.^[@bibr56-0269216317709965]^ Questions related to depressive feelings are often included in burden measures (e.g. I feel emotionally drained due to caring for him or her. Caregiver Burden Inventory item 9; Do you feel tired and worn out? Caregiver Burden Scale item 1). However, in this review, we conceived caregiver burden and depression as two separate concepts because caregiver burden represents outcomes specific to the caregiving situation, while measurements of depression represent a more general outcome.

In previous systematic reviews, the suggestion was made that social support might be a protective factor for caregiver burden,^[@bibr12-0269216317709965],[@bibr57-0269216317709965]^ but this result could not be confirmed in our review. This difference might be attributed to the inclusion of both quantitative and qualitative studies. An alternative explanation could be that only specific subtypes of social support (i.e. emotional, instrumental, informational, or appraisal support)^[@bibr58-0269216317709965]^ mitigate caregiver burden. For example, the benefits of receiving social support in caregiving (instrumental support) may be overestimated in ALS care, as taking over caregiving tasks is complicated, especially in later stages of the disease. Family members and friends are often not equipped to offer this specialized care to the patient.^[@bibr4-0269216317709965]^ Hence, relieving the burden of the caregiver by providing physical support in caregiving seems to be a difficult task for their social environment, while relieving caregiver burden with emotional support may be more feasible. However, it was impossible to make this differentiation in our review due to scarcity of research in this topic.

This systematic review offers insight into factors related to caregiver burden and guides the development of interventions aiming to reduce caregiver burden, but more additional research into factors related to caregiver burden is needed. Personal factors of ALS caregivers are possible modifiable factors but are currently understudied. Only 6 out of 25 of the studies included in this review paid attention to these factors. More knowledge about personal caregiver factors, such as feelings of competence in caregiving or self-efficacy, is needed since these personal factors seem to play a protective role in the development of burden in caregivers of patients with dementia.^[@bibr59-0269216317709965]^

Strengths and limitations {#section26-0269216317709965}
=========================

This review was carried out in accordance with the PRISMA guidelines; the quality of the evidence was judged by assessing the risk of bias, and the GRADE approach was used, which are strengths of this review.

There were also some limitations of the review. First, it was not possible to perform a meta-analysis because of the heterogeneity of both the measures used to assess caregiver burden and the measures used to assess the associated factors.

Second, the instruments used to assess caregiver burden represented different interpretations of the concept, caregiver burden. Therefore, we only included studies which assessed a total score on burden as this represents a general concept of burden. Others have suggested, however, that the use of multidimensional measures of caregiver burden might provide different information.^[@bibr60-0269216317709965]^ For the interpretation of results on caregiver burden, and the comparison of intervention effects, a gold standard for the measurement of burden in ALS caregivers would be preferable.

Third, we only included full-text, peer-reviewed published studies and therefore might have missed evidence about relationships between patient and caregiver factors and caregiver burden.

Finally, the overwhelming majority of studies was cross-sectional and does not, therefore, allow any causal inferences between caregiver burden and factors. Longitudinal data are required to understand the temporal pattern of caregiver burden, its determinants, and the optimal time to deliver an intervention to diminish caregiver burden.

Conclusion {#section27-0269216317709965}
==========

This review presents the current knowledge on associations between both patient factors and caregiver factors which are related to caregiver burden in ALS caregivers. There is moderate to high quality of evidence for the relation between behavioral impairments of the patient and caregiver burden, physical functioning of the patient and caregiver burden, and feelings of depression of the caregiver himself or herself and caregiver burden. This is important knowledge in order to identify those caregivers who are at risk of caregiver burden and to inform the development of interventions focusing on diminishing burden in caregivers of ALS patients.
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